Immunic AG is a startup based in Germany, most recent round Series-c-plus, 3 tracked investors.
Immunic AG is a startup founded in 2007 based in Germany. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Immunic is a late-stage biotechnology company developing orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, including multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.